RBC Europe’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-150
| Closed | -$5.45K | – | 1033 |
|
2021
Q3 | $5.45K | Hold |
150
| – | – | ﹤0.01% | 1031 |
|
2021
Q2 | $6.51K | Hold |
150
| – | – | ﹤0.01% | 1022 |
|
2021
Q1 | $5.13K | Hold |
150
| – | – | ﹤0.01% | 1001 |
|
2020
Q4 | $5.25K | Hold |
150
| – | – | ﹤0.01% | 966 |
|
2020
Q3 | $3.6K | Hold |
150
| – | – | ﹤0.01% | 931 |
|
2020
Q2 | $2.75K | Hold |
150
| – | – | ﹤0.01% | 928 |
|
2020
Q1 | $2.34K | Hold |
150
| – | – | ﹤0.01% | 901 |
|
2019
Q4 | $3.21K | Hold |
150
| – | – | ﹤0.01% | 930 |
|
2019
Q3 | $2.81K | Hold |
150
| – | – | ﹤0.01% | 941 |
|
2019
Q2 | $3.92K | Hold |
150
| – | – | ﹤0.01% | 939 |
|
2019
Q1 | $3.86K | Hold |
150
| – | – | ﹤0.01% | 952 |
|
2018
Q4 | $3.45K | Hold |
150
| – | – | ﹤0.01% | 955 |
|
2018
Q3 | $4.82K | Hold |
150
| – | – | ﹤0.01% | 967 |
|
2018
Q2 | $4.25K | Hold |
150
| – | – | ﹤0.01% | 987 |
|
2018
Q1 | $5.31K | Hold |
150
| – | – | ﹤0.01% | 935 |
|
2017
Q4 | $5.82K | Hold |
150
| – | – | ﹤0.01% | 926 |
|
2017
Q3 | $3.81K | Buy |
+150
| New | +$3.81K | ﹤0.01% | 995 |
|